Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$407M |
| 2 |
ExxonMobil
XOM
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$200M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$43M |
| 3 |
BCE
BCE
|
+$39M |
| 4 |
PETM
PETSMART INC
PETM
|
+$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 10.89% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Norwegian Cruise Line
NCLH
$8.59B
| $9.38M | 0.03% |
173,700
+89,100
| +105% | +$4.26M |
|
577
Avnet
AVT
$7.87B
| $9.3M | 0.02% |
209,032
+81,100
| +63% | +$3.58M |
|
578
United Therapeutics
UTHR
$22.1B
| $9.29M | 0.02% |
53,900
+700
| +1% | +$107K |
|
|
TTM
579
DELISTED
Tata Motors Limited
TTM
| $9.27M | 0.02% |
+205,661
| New | +$9.7M |
|
580
News Corp Class A
NWSA
$15.5B
| $9.25M | 0.02% |
577,699
+226,800
| +65% | +$3.67M |
|
581
Quanta Services
PWR
$101B
| $9.21M | 0.02% |
323,009
+126,200
| +64% | +$3.54M |
|
582
Iron Mountain
IRM
$36.4B
| $9.12M | 0.02% |
249,991
+95,100
| +61% | +$3.67M |
|
583
Arrow Electronics
ARW
$10.5B
| $9.08M | 0.02% |
148,448
+56,700
| +62% | +$3.37M |
|
584
Albemarle
ALB
$15.3B
| $9.03M | 0.02% |
170,906
+98,206
| +135% | +$5.36M |
|
585
Jacobs Solutions
J
$17.3B
| $9.03M | 0.02% |
241,604
+93,332
| +63% | +$3.28M |
|
586
Centene
CNC
$32.1B
| $8.89M | 0.02% |
251,400
+1,400
| +0.6% | +$42.1K |
|
587
Packaging Corp of America
PKG
$22.9B
| $8.86M | 0.02% |
113,300
+1,200
| +1% | +$95.2K |
|
|
WWAV
588
DELISTED
The WhiteWave Foods Company
WWAV
| $8.84M | 0.02% |
199,371
+2,000
| +1% | +$76.4K |
|
|
TEG
589
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $8.76M | 0.02% |
121,565
+47,600
| +64% | +$3.64M |
|
590
Alnylam Pharmaceuticals
ALNY
$29.6B
| $8.65M | 0.02% |
82,800
+11,200
| +16% | +$1.13M |
|
591
Marvell Technology
MRVL
$191B
| $8.64M | 0.02% |
587,672
+233,300
| +66% | +$3.69M |
|
592
Oceaneering
OII
$5.05B
| $8.63M | 0.02% |
160,000
+60,000
| +60% | +$3.2M |
|
593
Fortune Brands Innovations
FBIN
$5.97B
| $8.6M | 0.02% |
212,004
+1,287
| +0.6% | +$50.1K |
|
594
Gartner
IT
$11.8B
| $8.6M | 0.02% |
102,600
+400
| +0.4% | +$33K |
|
595
Jones Lang LaSalle
JLL
$16.7B
| $8.54M | 0.02% |
50,100
+500
| +1% | +$78.9K |
|
596
Arthur J. Gallagher & Co
AJG
$65B
| $8.51M | 0.02% |
182,120
+8,100
| +5% | +$378K |
|
597
Idexx Laboratories
IDXX
$46.2B
| $8.5M | 0.02% |
110,000
-3,200
| -3% | -$249K |
|
|
WLL
598
DELISTED
Whiting Petroleum Corporation
WLL
| $8.49M | 0.02% |
916
+400
| +78% | +$4.05M |
|
599
Extra Space Storage
EXR
$31B
| $8.46M | 0.02% |
125,200
+1,500
| +1% | +$98.4K |
|
|
CDK
600
DELISTED
CDK Global, Inc.
CDK
| $8.45M | 0.02% |
180,800
+4,700
| +3% | +$214K |
|
Similar funds
Swiss National Bank's Q1 2015 Portfolio in Review
As of Q1 2015, Swiss National Bank held 2,582 positions worth $37.5B, up 40% from $26.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $10.3B of net new capital in Q1 2015, opening 14 new positions and adding to 1,633 existing holdings. Its largest new stake was Infosys: 2,143,352 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BCE, an estimated $39M trimmed.
- Swiss National Bank's largest Q1 2015 buy was Infosys: 2,143,352 shares worth $18.8M.
- Swiss National Bank added most to Apple in Q1 2015, an estimated $407M increase.
- Swiss National Bank's biggest Q1 2015 reduction was BCE, cutting an estimated $39M.
- Swiss National Bank fully exited Allergan Inc in Q1 2015, selling an estimated $58.6M.
- Swiss National Bank's ten largest holdings make up 14% of its $37.5B portfolio in Q1 2015.
- Swiss National Bank opened 14 new positions and closed 36 in Q1 2015.
- Swiss National Bank's portfolio value rose 40% quarter-over-quarter to $37.5B.
Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.